Home / Inspections / 1192104

FDA Inspection 1192104 — Novartis Pharma Stein AG

Novartis Pharma Stein AG — FEI 3002653483

The FDA completed an inspection of Novartis Pharma Stein AG on December 6, 2022 in Stein Ag. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 6, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Stein Ag (Switzerland)

Facility

Other inspections at this facility

  • 1073408 (VAI Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1015468 (VAI Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 947993 (VAI Fri Oct 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 924507 (NAI Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 875305 (NAI Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources